12-50401022-C-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_052879.5(LARP4):c.12C>A(p.Phe4Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000088 in 1,614,096 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_052879.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
LARP4 | NM_052879.5 | c.12C>A | p.Phe4Leu | missense_variant | 1/16 | ENST00000398473.7 | NP_443111.4 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
LARP4 | ENST00000398473.7 | c.12C>A | p.Phe4Leu | missense_variant | 1/16 | 1 | NM_052879.5 | ENSP00000381490 | P5 |
Frequencies
GnomAD3 genomes AF: 0.000532 AC: 81AN: 152126Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000842 AC: 21AN: 249534Hom.: 0 AF XY: 0.0000665 AC XY: 9AN XY: 135388
GnomAD4 exome AF: 0.0000417 AC: 61AN: 1461852Hom.: 0 Cov.: 30 AF XY: 0.0000371 AC XY: 27AN XY: 727232
GnomAD4 genome AF: 0.000532 AC: 81AN: 152244Hom.: 0 Cov.: 32 AF XY: 0.000443 AC XY: 33AN XY: 74430
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Feb 14, 2024 | The c.12C>A (p.F4L) alteration is located in exon 1 (coding exon 1) of the LARP4 gene. This alteration results from a C to A substitution at nucleotide position 12, causing the phenylalanine (F) at amino acid position 4 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at